Join        Login             Stock Quote

Merit Medical (MMSI) Buys Assets of Peritoneal Dialysis Catheters Maker Medigroup

 November 29, 2012 11:47 AM

(By Balaseshan) Merit Medical Systems Inc. (NASDAQ: MMSI) said it purchased substantially all of the assets of Illinois-based peritoneal dialysis catheters manufacturer Medigroup Inc.

Medigroup is profitable with 75 percent gross margins, and the South Jordan, Utah-based Merit Medical expects the transaction will be immediately accretive for the company.

Medigroup's current annual sales are about $2 million, mostly in the United States, and Merit Medical intends to offer the product line immediately on a worldwide basis.

The company said that while growing in the United States, peritoneal dialysis is the procedure of choice over chronic catheters in many international markets.

[Related -Medical Supply Stocks To Get Hit By The Taxman, Yeah, The Taxman]

"Medigroup offers a broad product line of catheters and implantation devices, and we believe this opportunity will enhance our overall dialysis business," said Fred Lampropoulos, chairman and chief executive officer of Merit Medical.

Merit Medical designs, develops, manufactures and markets medical devices used in interventional and diagnostic procedures. The company operates in the cardiology, radiology, pulmonology, thoracic surgery, nephrology, vascular surgery and gastroenterology markets.

Merit employs about 2,600 people worldwide with facilities in Salt Lake City and South Jordan, Utah; Angleton, Texas; Richmond, Virginia; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Copenhagen, Denmark; and Rockland, Massachusetts.

[Related -Merit Medical (MMSI) To Market Merit Laureate Hydrophilic Guide Wire]

MMSI is trading up 1.08 percent at $14.04 on Thursday. The stock has been trading between $11.51 and $15.37 for the past 52 weeks.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.